It’s All in the “Swerve of the Curve” Daniel J Boffa, MD Journal of Thoracic Oncology Volume 11, Issue 11, (November 2016) DOI: 10.1016/j.jtho.2016.09.004 Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions
Figure 1 Kaplan-Meier survival curves with 90-day mortalities excluded for all resected T3 tumors with additional tumor nodules (T3N0-2M0) (A) and T3 additional nodule–only cohort (T3 additional nodule cohort in which patients with other T3 indicators such as size or invasion or patients with lymph node metastases had been excluded [T3N0M0]) (B). Journal of Thoracic Oncology 2016 11, DOI: (10.1016/j.jtho.2016.09.004) Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions